Substitution and glucocorticoids treatment
Mattsson, C.; Olsson, T.
Lakartidningen 105(3): 144
2008
ISSN/ISBN: 0023-7205 PMID: 18290514 Document Number: 620153
Document emailed within 1 workday
Related Documents
Boissonnas, A. 1994: How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections? Annales de Medecine Interne 145 Suppl. 3: 54-55Fijałkowski, M.; Graczyk, J. 2003: Glucocorticoids in the treatment of tuberculous pleurisy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(87): 288-291
Fujimura, K. 2003: Glucocorticoids therapy as a first line treatment in ITP Nihon Rinsho. Japanese Journal of Clinical Medicine 61(4): 593-598
Muñoz Díaz, L. 1971: Glucocorticoids in the treatment of bronchial asthma Revista Clinica Espanola 120(5): 467-472
Sönnichsen, N.; Kluge, K. 1971: Treatment of arthropathic psoriasis with antimetabolites and glucocorticoids Dermatologische Monatschrift 157(5): 334-337
Gherzi, R.; Cottafavi, M. 1979: Changes in fetal lung maturity after maternal treatment with glucocorticoids Minerva Ginecologica 31(11): 815-820
Hostomská, L.; Brachfeldová, J.; Nováková, M.; Snobl, O. 1975: Problems with glucocorticoids in the treatment of congenital adrenogenital syndrome Ceskoslovenska Pediatrie 30(9): 393-397
Autret, E. 1992: Role of glucocorticoids in the treatment of bacterial meningitis in children Archives Francaises de Pediatrie 49(4): 385-388
Töx, U.; Goeser, T.; Steffen, H.M. 2001: Ulcer prevention during long term treatment with glucocorticoids? Deutsche Medizinische Wochenschrift 126(25-26): 764-766
Hitzig, W.H. 1983: Humoral immunodeficiencies and their substitution treatment Presse Medicale 12(41): 2563-2566
Fuentes, A.; Feliu, E.; Blade, J.; Campo, E.; Ribera, J.M.; Cervantes, F.; Rozman, C. 1996: Splenomegalic pancytopenia of probable immune origin: cure after treatment with glucocorticoids Medicina Clinica 106(7): 263-266
Taran, E.I.; Bozhko, E.G.; Kolesnik, N.A. 1985: Morphological criteria for predicting the effectiveness of treatment of glomerulonephritis with glucocorticoids and cytostatics Vrachebnoe Delo 3: 64-68
Zierott, G. 1970: Volume substitution and vasoactive pharmaca in the treatment of shock Deutsche Medizinische Wochenschrift 95(48): 2452-2455
Lauritzen, C. 1990: Colorectal carcinoma and substitution hormone treatment in menopause Zentralblatt für Gynakologie 112(23): 1493-1494
Fischer, B.; Rehm, J. 1997: The case for a heroin substitution treatment trial in Canada Canadian Journal of Public Health 88(6): 367-370
Deering, D.; Sellman, J.D.; Adamson, S. 2014: Opioid substitution treatment in new Zealand: a 40 year perspective New Zealand Medical Journal 127(1397): 57-66
Sanzharovskiĭ, G.Ia. 1977: Lumbar retroperitoneal novocaine block supplemented with antihistamine and glucocorticoids in treatment of acute pancreatitis Vestnik Khirurgii Imeni I. I. Grekova 119(7): 58-62
Zefirova, G.S.; Ibragimova, G.V.; Beĭsugurov, M.S.; Shmushkovich, B.I. 1986: Status of the hypophysis-adrenal cortex system during treatment with glucocorticoids by the method of intermittent (every other day) administration Terapevticheskii Arkhiv 58(10): 114-117
Siegel, I. 1996: Possibilities and limits of drug substitution treatment in ambulatory practice Zeitschrift für Arztliche Fortbildung 90(4): 307-313
Elias, H. 1990: Drug substitution in treatment of substance dependence in general practice Verhandlungen der Deutschen Gesellschaft für Innere Medizin 96: 601-605